GlaxoSmithKline plc news

   Watch this stock
Showing stories 1 - 10 of about 167   

Articles published

GSK 1,439.00 -17.00 (-1.17%)
price chart
Should You Buy Warren Buffett's British Rejects Tesco PLC, GlaxoSmithKline plc ...
Renowned investor Warren Buffett doesn't venture outside his US backyard that often. But Tesco (LSE: TSCO), GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) and Diageo (LSE: DGE) (NYSE: DEO.US) are three FTSE 100 companies that share the distinction ...
Why GlaxoSmithKline plc Is More Like Unilever plc Than AstraZeneca plc
It used to be that investors in big pharma had a straight choice between GlaxoSmithKline (LSE: GSK) (NYSE:GSK.US) and AstraZeneca (LSE:AZN) (NYSE: AZN.US). They remain the two largest firms in the pharmaceutical sector of the London Stock ...
Closing Bell Reports: Ocwen Financial Corp. (OCN), GlaxoSmithKline plc (GSK ...  WallStreet Scope
Company Shares of GlaxoSmithKline PLC Drops by -1.97%  The Daily Rover
GlaxoSmithKline plc Earns "Underperform" Rating from BNP Paribas (GSK)
GlaxoSmithKline plc logo GlaxoSmithKline plc (LON:GSK)'s stock had its “underperform” rating reissued by equities researchers at BNP Paribas in a research report issued on Tuesday.
GlaxoSmithKline plc Receives "Underperform" Rating from BNP ...  WKRB News
3 Blue-Chip Marvels Trading At Unmissable Prices: GlaxoSmithKline plc ...
The problem of serious patent losses continues to stunt investor appetite for pharma plays such as GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US). Shares in the firm have steadily declined in recent weeks and have shed more than 10% since mid-April, but I ...
Analytic Report on GlaxoSmithKline PLC (ADR) (NYSE:GSK)  Street Report
Pre Movers- ANN INC. (NYSE:ANN), GlaxoSmithKline plc (NYSE:GSK), HSBC ...  StreetWise Report
Gilead Sciences, Inc., GlaxoSmithKline plc, Johnson & Johnson Looking To Gain ...
The approved HIV drugs used in the trial were supplied by AbbVie Inc (NYSE:ABBV), Bristol-Myers Squibb Co (NYSE:BMY), Gilead Sciences, Inc. (NASDAQ:GILD), GlaxoSmithKline plc (ADR) (NYSE:GSK), Janssen Scientific Affairs of Johnson and Johnson ...
GlaxoSmithKline plc (ADR)(GSK): A Big Pharma Stock With A Very Big Dividend
biotech Bob Ciura: Dividend stocks are abundant within the highly profitable health care and pharmaceutical sectors. But the biggest dividend among Big Pharma stocks belongs to GlaxoSmithKline PLC (NYSE:GSK). The Brentford, England-based company's ...
GlaxoSmithKline plc Rating Reiterated by JPMorgan Chase & Co. (GSK)  Dakota Financial News
GlaxoSmithKline plc 7.1% Potential Upside Indicated by Citigroup  DirectorsTalk Interviews
Better Dividend Stock: Pfizer, Inc. or GlaxoSmithKline plc?
Within the healthcare sector, Pfizer (NYSE:PFE) and GlaxoSmithKline (NYSE:GSK) are two popular dividend stocks because they have strong brands and a long history of paying out dividends, and they dole out a higher-than-average yield.
GlaxoSmithKline plc To Go Ex-Dividend on May 13th (GSK)  Dakota Financial News
GlaxoSmithKline: Out of step  Financial Times
Recent Analysts' Ratings Updates for GlaxoSmithKline plc (GSK)
5/28/2015 - GlaxoSmithKline plc had its “market perform” rating reaffirmed by analysts at Sanford C. Bernstein. They now have a GBX 1,410 ($21.82) price target on the stock.
Sanford C. Bernstein Reiterates "Market Perform" Rating for ...  sleekmoney
GlaxoSmithKline plc (GSK) - Investment Analysts' Recent Ratings Changes  WKRB News
What This Top Dividend Portfolio Is Holding Now: GlaxoSmithKline plc, Royal ...
Top FTSE 100 pharmaceuticals firm GlaxoSmithKline still does blockbuster drugs, but Merchants likes the way the company has been consolidating its global leadership positions in vaccines and consumer health, where there are “scale advantages” and ...
GlaxoSmithKline PLC Earnings: Pay No Attention to the Results Behind the Curtain
The U.S. stock market has risen substantially over the trailing year, but don't tell that to GlaxoSmithKline (NYSE:GSK) shareholders who've witnessed their stock give up about 20% of its value over the past 12-month period. Like most Big Pharma stocks, ...
GlaxoSmithKline plc (ADR) (GSK) Stock Up 3% After New Chairman Reiterates ...  Bidness ETC